Guidant Wealth Advisors held its stake in Clorox Company (The) (NYSE:CLX) during the second quarter, Holdings Channel reports. The firm owned 800 shares of the company’s stock at the end of the second quarter. Guidant Wealth Advisors’ holdings in Clorox Company (The) were worth $106,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. American Beacon Advisors Inc. purchased a new stake in Clorox Company (The) during the first quarter worth $104,000. Parkside Financial Bank & Trust increased its stake in Clorox Company (The) by 3.8% in the second quarter. Parkside Financial Bank & Trust now owns 796 shares of the company’s stock worth $107,000 after buying an additional 29 shares during the last quarter. Valley National Advisers Inc. increased its stake in Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock worth $116,000 after buying an additional 5 shares during the last quarter. Blue Chip Partners Inc. increased its stake in Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock worth $122,000 after buying an additional 6 shares during the last quarter. Finally, Zions Bancorporation increased its stake in Clorox Company (The) by 5.6% in the first quarter. Zions Bancorporation now owns 992 shares of the company’s stock worth $134,000 after buying an additional 53 shares during the last quarter. Institutional investors and hedge funds own 69.83% of the company’s stock.

Shares of Clorox Company (NYSE:CLX) opened at 136.30 on Wednesday. The company has a market capitalization of $17.60 billion, a PE ratio of 25.55 and a beta of 0.40. Clorox Company has a 1-year low of $111.24 and a 1-year high of $141.76. The company has a 50 day moving average price of $133.40 and a 200 day moving average price of $133.95.

Clorox Company (The) (NYSE:CLX) last announced its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.04. The firm had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.65 billion. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The business’s revenue was up 2.9% compared to the same quarter last year. During the same period in the prior year, the company earned $1.30 EPS. Equities analysts predict that Clorox Company will post $5.67 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: “Clorox Company (The) (CLX) Position Held by Guidant Wealth Advisors” was originally reported by Watch List News and is the property of of Watch List News. If you are viewing this report on another domain, it was illegally copied and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be read at https://www.watchlistnews.com/clorox-company-the-clx-position-held-by-guidant-wealth-advisors/1493527.html.

A number of equities research analysts have weighed in on CLX shares. Zacks Investment Research upgraded Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 price target on the stock in a research report on Tuesday, July 4th. Vetr upgraded Clorox Company (The) from a “hold” rating to a “buy” rating and set a $139.67 price target on the stock in a research report on Monday, April 24th. BMO Capital Markets reaffirmed a “buy” rating and set a $136.00 price objective on shares of Clorox Company (The) in a research note on Thursday, May 4th. Barclays PLC reaffirmed an “equal weight” rating and set a $136.00 price objective (down from $140.00) on shares of Clorox Company (The) in a research note on Friday, August 4th. Finally, Jefferies Group LLC set a $138.00 price objective on Clorox Company (The) and gave the company a “hold” rating in a research note on Wednesday, May 3rd. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating and three have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $129.05.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Clorox Company (The) (NYSE:CLX).

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with Analyst Ratings Network's FREE daily email newsletter.